OsNovum

OsNovum

Early Stage

Revolutionizing skeletal health through the science of bone regeneration

Revolutionizing skeletal health through the science of bone regeneration

Overview

Raised this Round: Raised: $24,851

Total Commitments ($USD)

Platform

Wefunder

Start Date

06/16/2024

Close Date

10/31/2024

Min. Goal
$50,000
Max. Goal
$124,000
Min. Investment

$100

Security Type

Equity - Preferred

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$40.00

Pre-Money Valuation

$19,532,200

Year Founded

2020

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

Medium

Capital Intensity

Location

Henderson, Nevada

Business Type

Growth

OsNovum, with a valuation of $19.53 million, is raising funds on Wefunder. The company has developed a patented technology to regenerate bones affected by osteoporosis. OsNovum’s technology aims to improve skeletal health and improve the lifespan and quality of life. The technology has already been cleared by the FDA for maxillofacial use and waiting for clearance for skeletal use. The company plans to launch specialty clinics based on its technology. Gregory Steiner and Roslynn Steiner founded OsNovum in June 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $124,000. The campaign proceeds will be used for FDA tests, ISO certification, regulatory submissions, legal fees, capital improvements, production equipment, and salaries.

Summary Profit and Loss Statement

FY 2023 FY 2022

Revenue

$5

$5

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-22,650

$-84,187

Summary Balance Sheet

FY 2023 FY 2022

Cash

$137

$18,144

Accounts Receivable

$0

$0

Total Assets

$137

$18,144

Short-Term Debt

$4,643

$0

Long-Term Debt

$0

$0

Total Liabilities

$4,643

$0

Financials as of: 06/16/2024
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
OsNovum 10/30/2024 Wefunder $19,532,200 $24,851 Equity - Preferred Active RegCF
OsNovum 03/30/2021 Wefunder $14,400,000 $204,350 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
OsNovum on Wefunder 2024
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $19,532,200
Price per Share: $40.00

Follow company

Follow OsNovum on Wefunder 2024

Buy OsNovum's Deal Report

OsNovum Deal Report

Get KingsCrowd’s comprehensive report on OsNovum including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether OsNovum is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the OsNovum deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge